Adjuvant chemotherapy for gastric cancer: a randomised phase 3 trial of mitomycin-C plus either short-term doxifluridine or long-term doxifluridine plus cisplatin after curative D2 gastrectomy (AMC0201)

Adjuvant chemotherapy for gastric cancer: a randomised phase 3 trial of mitomycin-C plus either short-term doxifluridine or long-term doxifluridine plus cisplatin after curative D2 gastrectomy (AMC0201)

Bibliographic Details
Main Authors: Kang, Y-K, Chang, H-M, Yook, J H, Ryu, M-H, Park, I, Min, Y J, Zang, D Y, Kim, G Y, Yang, D H, Jang, S J, Park, Y S, Lee, J-L, Kim, T W, Oh, S T, Park, B K, Jung, H-Y, Kim, B S
Format: Online
Language:English
Published: Nature Publishing Group 2013
Online Access:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3619263/

Similar Items

Similar Items